Their results demonstrated higher unstimulated levels of interleukin 6 (IL-6), IL-1β, tumor necrosis factor α, interferon γ, IL-10, IL-8, macrophage inflammatory protein 1α (MIP1α) and 1β (MIP1β) and higher stimulated levels of IL-6, IL-8, IL-10, MIP1α and MIP1β in T2D. The gene discussed is CCL4; the disease is type 2 diabetes mellitus.